Leap Investments’s Immunogen Inc IMGN Stock Holding History

Leap Investments’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-46,553	Closed	-$238K	–	608
2019 Q4	$238K	Buy	+46,553	New	+$158K	0.11%	289

Other funds holding IMGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Leap Investments's IMGN Position: Q1 2020 in Review

Leap Investments sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 46,553 shares — an estimated $238K sold.

Leap Investments first reported a position in IMGN in Q4 2019 and held it in 1 quarter. The position peaked at $238K in Q4 2019. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

Leap Investments reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 46,553 Immunogen Inc shares in Q1 2020, an estimated $238K.
Leap Investments first reported a position in Immunogen Inc in Q4 2019 and held it in 1 quarter.
Leap Investments's Immunogen Inc position peaked at $238K in Q4 2019.
185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.